Clinical Trials Browser

OTHER × Neoplasms, Plasma Cell × Transplantation, Autologous × Clear all

NCT02244125 2025-11-24

PCD

Phase 2 Completed

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT00950768 2009-08-03

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Phase 3 Completed

Disease, Multiple Myeloma, Neoplasms, Plasma Cell